XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 154,511 $ 202,004
Marketable securities available-for-sale 565,905 422,391
Accounts receivables, net of allowance for doubtful accounts of $12,313 and $0 at September 30, 2023 and December 31, 2022, respectively 46,347 145,130
Other receivables 519 2,385
Inventories 49,412 59,446
Prepaid expenses and other current assets 18,972 85,629
Total current assets 835,666 916,985
Property and equipment, net 36,183 37,596
Operating lease right-of-use assets 24,949 25,745
Goodwill 1,981 2,006
Other assets 74,154 3,518
Total assets 972,933 985,850
Current liabilities:    
Accounts payable 3,120 3,211
Accrued research and development 3,290 4,775
CEPI accrual (Note 6) 0 107,738
Accrued liabilities 43,462 30,719
Other current liabilities 4,392 3,631
Total current liabilities 54,264 150,074
Convertible Notes, net of debt discount of $3,085 and $3,922 at September 30, 2023 and December 31, 2022, respectively (Note 7) 222,415 221,578
Long-term portion of lease liabilities 30,680 32,801
CEPI accrual long-term 60,337 0
Other long-term liabilities 321 384
Total liabilities 368,017 404,837
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock: $0.001 par value; 5,000 shares authorized at September 30, 2023 and December 31, 2022; zero shares outstanding at September 30, 2023 and December 31, 2022, respectively 0 0
Common stock: $0.001 par value; 278,000 shares authorized at September 30, 2023 and December 31, 2022; 129,195 shares and 127,604 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 129 128
Additional paid-in capital 1,541,549 1,510,518
Accumulated other comprehensive loss (5,959) (5,438)
Accumulated deficit (930,803) (924,195)
Total stockholders’ equity 604,916 581,013
Total liabilities and stockholders’ equity $ 972,933 $ 985,850